Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 602 49 982.8 |
96 | EP file number | EAKZ | 18 15 5724.0 |
97 | EP publication number | EPN | 3342411 |
54 | Designation/title | TI | RAPAMYCIN-DERIVAT ZUR BEHANDLUNG VON BAUCHSPEICHELDRÜSENKREBS |
51 | IPC main class | ICM (ICMV) | A61K 31/436 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 35/00 (2006.01) |
22 | DE application date | DAT | Feb 18, 2002 |
96 | EP application date | EAT | Feb 18, 2002 |
43 | Date of first publication | OT | Jul 4, 2018 |
| Date of publication of grant | PET | Aug 21, 2019 |
71/73 | Applicant/owner | INH | Novartis Pharma AG, Basel, CH |
72 | Inventor | IN | Lane, Heidi, 4106 Therwill, CH; O`Reilly, Terence, 4057 Basel, CH; Wood, Jeanette Marjorie, 4105 Biel-Benken, CH |
| Address for service | | Novartis Pharma AG, 4056 BASEL, CH |
33 31 32
| Foreign priority | PRC PRNA PRDA
| GB 0124957 Oct 17, 2001
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| GB 0104072 Feb 19, 2001
|
| Patent division in charge | | 44 |
21 | File number of protection certificate | ZAKZ | 12 2020 000 008.6 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003342411A1 Searchable text:
EP000003342411A1 Original document:
EP000003342411B1 Searchable text:
EP000003342411B1 |
43 | Date of first publication | EVT | Jul 4, 2018 |
| Date of the first transfer into DPMAregister | EREGT | Jul 4, 2018 |
| Date of the (most recent) update in DPMAregister | REGT | Feb 8, 2024 (Show all update days)(Hide all update days)- Feb 8, 2024; Jan 4, 2024; Feb 20, 2022; Feb 12, 2021; Jul 16, 2020; Jun 25, 2020; Mar 5, 2020; Feb 14, 2020; Oct 17, 2019; Sep 12, 2019; Aug 23, 2019; Aug 3, 2019; Aug 1, 2019; Apr 4, 2019
- Historical data not available for this/these date(s)
- Jul 4, 2018
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 6)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jun 24, 2020 |
| Issue number | HN | 31 |
| Year | PJ | 2020 |
| Publication date | VT | Jul 30, 2020 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Novartis Pharma AG, Basel, CH |
71/73 | Previous applicant/owner | INHF | Novartis International Pharmaceutical AG, Basel, CH, Novartis Pharma AG, Basel, CH |
| Date of update of the procedure | REGT | Jul 16, 2020 |